Withdrawal of 60-Day Notice of Proposed Information Collection: Unaccompanied Children Case Summary Form, 76949 [2016-26686]
Download as PDF
<![CDATA[
76949
Federal Register / Vol. 81, No. 214 / Friday, November 4, 2016 / Notices
Tribes and Tribal organizations must
respond if they wish to operate a fully
funded program. This paperwork
collection activity is set to expire in
December, 2016.
Respondents: Tribes and Tribal
Organizations.
ANNUAL BURDEN ESTIMATES
Number of
responses per
respondent
Number of
respondents
Instrument
Average
burden hours
per response
Total
burden hours
45 CFR 309 Amended Plan ............................................................................
45 CFR 309 New Plan ....................................................................................
63
2
1
1
120
480
7,560
960
Total ..........................................................................................................
........................
........................
600
8,520
Estimated Total Annual Burden Hours ..............................................
........................
........................
600
8,520
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 330
C Street SW., Washington, DC 20201.
Attention Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV. Attn:
Desk Officer for the Administration for
Children and Families
Summary Form.’’ ACF is withdrawing
this notice from the Federal Register.
FOR FURTHER INFORMATION CONTACT:
Robert Sargis, Reports Clearance Officer,
Office of Planning Research and
Evaluation.
Robert Sargis,
Reports Clearance Officer.
AGENCY:
[FR Doc. 2016–26615 Filed 11–3–16; 8:45 am]
ACTION:
BILLING CODE 4184–01–P
SUMMARY:
Administration for Children and
Families
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Withdrawal of 60-Day Notice of
Proposed Information Collection:
Unaccompanied Children Case
Summary Form
Administration for Children
and Families, HHS.
AGENCY:
Withdrawal: Notice.
On October 4, 2016 at 81 FR
68420, ACF published a 60 Day Notice
of Proposed Information Collection
entitled ‘‘Unaccompanied Children Case
SUMMARY:
VerDate Sep<11>2014
17:52 Nov 03, 2016
[FR Doc. 2016–26686 Filed 11–3–16; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Aging (NIA),
National Institute of Mental Health
(NIMH), and National Center for
Advancing Translational Sciences
(NCATS): Cooperative Research and
Development Agreement (CRADA) and
Licensing Opportunity for Ketamine for
the Treatment of Depression and Other
Anxiety-Related Disorders
National Institutes of Health,
HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Robert Sargis,
Reports Clearance Officer.
Jkt 241001
Notice.
The National Institute of
Aging (NIA), National Institute of
Mental Health (NIMH), and National
Center for Advancing Translational
Sciences (NCATS) of the National
Institutes of Health (NIH), University of
Maryland at Baltimore (UMB) and their
collaborators are seeking Cooperative
Research and Development Agreement
(CRADA) partners to collaborate in the
preclinical and clinical development of
ketamine metabolite (2R, 6R-HNK) for
the treatment of depression and other
anxiety-related disorders.
DATES: Interested candidate partners
must submit a statement of interest and
capability, no more than five pages long,
to the NCATS point of contact before
January 3, 2017 for consideration.
FOR FURTHER INFORMATION CONTACT:
Information on licensing and co-
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
development research collaborations,
and copies of the U.S. patent
applications listed below may be
obtained by contacting: Attn: Sury Vepa,
Ph.D., J.D., Senior Licensing and
Patenting Manager, National Center for
Advancing Translational Sciences, NIH,
9800 Medical Center Drive, Rockville,
MD 20850, Phone: 301–217–9197, Fax:
301–217–5736, or email
NCATSPartnerships@mail.nih.gov. A
signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
As per the
Anxiety and Depression Association of
America, Major depressive disorder
affects 14.8 million people in America,
including children, adults, and the
elderly. A number of therapies currently
exist to treat depression, although they
suffer drawbacks such as requiring
weeks to take action. One particular
therapy includes the approved drug,
ketamine, which has demonstrated
robust and acute antidepressant activity.
However, its efficacy is bridled with
significant disadvantages including its
addictive potential and its dissociative
activities. This is the case even when
administered at low doses, which limits
the potential widespread use of
ketamine as an antidepressant
medication.
In order to improve the treatment of
depression, it is important to explore
the mechanism by which ketamine
exerts its antidepressant effects. That is
precisely what the NIH and UMB
scientists and collaborators are
investigating, and have found that the
metabolism of ketamine is critical to its
antidepressant effects, and that the
(2R,6R)-2-amino-2-(2-chlorophenyl)-6hydroxycyclohexanone ((2R,6R)hydroxynorketamine (HNK)) metabolite,
reversed depression-like behaviors in
mice without triggering anesthetic,
dissociative, or addictive side effects
associated with ketamine. Specifically,
the researchers found that the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 81, Number 214 (Friday, November 4, 2016)]
[Notices]
[Page 76949]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26686]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Withdrawal of 60-Day Notice of Proposed Information Collection:
Unaccompanied Children Case Summary Form
AGENCY: Administration for Children and Families, HHS.
ACTION: Withdrawal: Notice.
-----------------------------------------------------------------------
SUMMARY: On October 4, 2016 at 81 FR 68420, ACF published a 60 Day
Notice of Proposed Information Collection entitled ``Unaccompanied
Children Case Summary Form.'' ACF is withdrawing this notice from the
Federal Register.
FOR FURTHER INFORMATION CONTACT: Robert Sargis, Reports Clearance
Officer, Office of Planning Research and Evaluation.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2016-26686 Filed 11-3-16; 8:45 am]
BILLING CODE 4184-01-P
